Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Ophthalmology Science, 2025
Plasma Proteomic Markers of IL-1β Pathway Associated with Incident Age-related Macular Degeneration in Persons with AIDS

Hunt P., Olshen A., Murad N. et al.

Olink Explore 3072/384Infectious DiseasesOphthalmologyPatient StratificationPlasma

Multiple Sclerosis and Related Disorders, 2025
Exploring the mediating role of cerebrospinal fluid metabolites in the pathway from circulating inflammatory proteins to multiple sclerosis: A Mendelian randomization study

Mao X., Lu X., Liu Y. et al.

Olink Target 96NeurologyPathophysiologyPlasma

CHEST, 2025
Characterizing Sarcoidosis Patients with Obstructive Respiratory Physiology

VanDerhoef D., Marka N., Langworthy B. et al.

Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPatient StratificationPlasma

Aging Cell, 2025
Identifying PDAP1 as a Biological Target on Human Longevity: Integration of Mendelian Randomization, Cohort, and Cell Experiments Validation Study

Hou T., Sha Z., Wang Q. et al.

Olink Target 96Olink Explore 3072/384AgingPathophysiologyPlasma

Nature Communications, 2025
Large-scale multi-omics analyses in Hispanic/Latino populations identify genes for cardiometabolic traits

Petty L., Chen H., Frankel E. et al.

Olink Explore 3072/384Metabolic DiseasesCross-platform Validation

American Journal of Respiratory and Critical Care Medicine, 2025
Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung Disease

Alqalyoobi S., Smith J., Maddali M. et al.

Olink Explore 3072/384Respiratory DiseasesPathophysiologyPatient StratificationPlasma

Clinical Cancer Research, 2025
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma

Jang H., Patel M., Wang D. et al.

Olink Explore HTOncologyImmunotherapyPathophysiologyPlasma

Nutrition & Metabolism, 2025
Unveiling the interplay among skin microbiota, cytokines, and T2DM: an insightful Mendelian randomization study

Zhang Z., Jiang C., Xing Y. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Nature, 2025
Translational genomics of osteoarthritis in 1,962,069 individuals

Hatzikotoulas K., Southam L., Stefansdottir L. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Nature Cancer, 2025
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis

Cousin S., Guégan J., Palmieri L. et al.

Olink Target 96OncologyPathophysiologyPlasma

Brain and Behavior, 2025
Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study

Wang H., Cheng Z., Xu Z. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Cell, 2025
Human proteome distribution atlas for tissue-specific plasma proteome dynamics

Malmström E., Malmström L., Hauri S. et al.

Olink Explore 3072/384Wider Proteomics StudiesData SciencePlasma

GeroScience, 2025
Associations between plasma proteomic signatures and secondary sleep in older adults

Madhawa K., Svensson T., Nt H. et al.

Olink Target 96NeurologyAgingPathophysiologyPlasma

Scientific Reports, 2025
Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis

Miclea A., Zurawski J., Healy B. et al.

Olink Target 96NeurologyPatient StratificationSerum

Thrombosis Journal, 2025
Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations

Daghlas I., Wang M., Gill D.

Olink Explore 3072/384CVDHematologyPathophysiologyPlasma

npj Precision Oncology, 2025
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment

Cui S., Zheng H., Xu Y. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Arthritis & Rheumatology, 2025
Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development

Rachid Zaim S., Savage A., Gillespie M. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

Cell Genomics, 2025
Integration of biobank-scale genetics and plasma proteomics reveals evidence for causal processes in asthma risk and heterogeneity

Donoghue L., Benner C., Chang D. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Cell Reports Medicine, 2025
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients

Hu M., Oliveira A., Fang Z. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Mediators of Inflammation, 2025
Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis

Wu Z., Yang J., Zhu Y. et al.

Olink Target 96AgingPathophysiologyPlasma

3391 publications